1st Quarter - Amendment

VAN NESS FELDMAN, LLP for MCKESSON CORPORATION

Firm
Client
Income
$70,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 22, 2013 $70,000 Replaced
1st Quarter - Amendment (this page) Apr 23, 2013 $70,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Incentives for health information technology, Affordable Care Act implementation and other healthcare policy issues. Proposed regulation of medical software.

LobbyistCovered position, as disclosed
NANCY MACAN MCNALLY —
JORDAN SMITH —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Federal Communications Commission (FCC)

Taxation/Internal Revenue Code TAX

Implementation of the new medical device tax. Proposals to repeal LIFO.

LobbyistCovered position, as disclosed
HOWARD J FELDMAN —
NANCY MACAN MCNALLY —
JORDAN SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Federal Communications Commission (FCC)

Veterans VET

Existing Department of Veterans' Affairs Pharmaceutical Prime Vendor Contract.

LobbyistCovered position, as disclosed
BEN LEE MCMAKIN —
NANCY MACAN MCNALLY —
JORDAN SMITH —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Federal Communications Commission (FCC)

Pharmacy PHA

Pharmacy issues Prescription drug supply chain issues, including security of the supply chain, drug shortages, prescription drug abuse and diversion.

LobbyistCovered position, as disclosed
NANCY MACAN MCNALLY —
JORDAN SMITH —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Federal Communications Commission (FCC); Food & Drug Administration (FDA); SENATE

Medicare/Medicaid MMM

Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 800 - A bill to remove the prompt pay discount between the manufacturer and the distributor from the providers Medicare Part B drug reimbursement.

LobbyistCovered position, as disclosed
NANCY MACAN MCNALLY —
JORDAN SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Federal Communications Commission (FCC)

Bills named: H.R. 800 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.